EIP hires litigation partner from Teva

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EIP hires litigation partner from Teva

jones-m-45.jpg

UK firm EIP has hired Matthew Jones as a partner in its London office, in the latest in a string of expansive moves by the firm

M Jones

Jones (right) joins from Teva Pharmaceuticals Europe where he worked on patent litigation, including Generics [UK] v Yeda & Teva over the drug Copaxone. The Court of Appeal ruled on the case in July 2013.

Jones has worked on other patent areas in the past, including electronics and telecoms. He worked alongside EIP's head of litigation Gary Moss at both McDermott Will & Emery and Taylor Wessing.

EIP opened an office in the US in May 2013, in San Diego – the first UK IP law firm to do so. It has also said it will open an office in Düsseldorf, Germany later this year.

The firm now has 18 partners, of which five work on litigation under the EIP Legal side of the firm. The remainder are patent and trade mark attorneys.

more from across site and SHARED ros bottom lb

More from across our site

The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Leaders at IP boutique say the decision to pursue sponsorless partnership with the specialised investment arm of a private equity firm comes at a time of ‘profound transformation’ in the profession
Gift this article